Is HIV Treatment HIV Prevention?

 

Join us for a conversation on the science and controversies surrounding the use of anti-HIV drugs to prevent the HIV transmission and acquisition. Recent studies offer evidence and raise questions about the role of antiretroviral medications in curbing the spread of HIV. Are HIV-positive people who take antiretroviral drugs less likely to transmit the virus? Can these same drugs taken by HIV-negative people help keep them negative? And if so, what are the ethical, financial, and health issues surrounding these HIV prevention strategies? Join us for a conversation on the science and controversies surrounding the use of anti-HIV drugs to prevent HIV transmission and acquisition.

HIVision is an ongoing forum series bringing research and evidence to bear on timely policy and programmatic issues. As thinking on HIV/AIDS continues to evolve, HIVision provides a safe venue to engage the community on potentially controversial topics.

 

Featured Panelists:

Lisa C. Capaldini, M.D.
Clinic Director, Castro Medical Group
Assistant Clinical Professor of Medicine, UCSF
Clinical Instructor, UCSF Department of Nursing

Moupali Das-Douglas, M.D.
Director of Research, HIV Prevention Section, SFDPH
Assistant Clinical Professor, AIDS/Infectious Diseases, UCSF

Robert Grant, M.D.
Investigator, Gladstone Institute of Virology & Immunology
Associate Professor, UCSF

Dana Van Gorder
Executive Director, Project Inform

Moderated By:

Judith Auerbach, Ph.D.
Vice President, Science & Public Policy, San Francisco AIDS Foundation